A director of biotech company Genzyme Corp. exercised options for 27,000 shares of common stock, according to a Securities and Exchange Commission filing Tuesday.
In a Form 4 filed with the SEC, Charles L. Cooney reported he exercised options for the shares on Friday for $32.52 and $43.90 apiece, and then sold them all the same day for $70.67 apiece.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
Genzyme is based in Cambridge, Mass.
Terms & Conditions
RSS Headlines
Fool UK